Loyens & Loeff hired Daniel Dedeyan (pictured) as a new partner. The addition is set to bolster the firm’s Banking & Finance practice. Dedeyan moves to Loyens & Loeff from a counsel position at
Tags :Loyens & Loeff
Loyens & Loeff advised Swiss data management specialist Redslim Group and its founders on the sale of a majority stake to Astorg Private Equity. Loyens & Loeff’s Swiss team acted as tax and
Loyens & Loeff advised alternative investment firm H.I.G. Capital in connection with its investment in German IT company Timetoact Group. The context Headquartered in Cologne, Timetoact specialises in cloud platforms and digital
American payment processing company Shift4 agreed to acquire specialty payments platform Global Blue. Loyens & Loeff has been advising the buyer, while NKF represented the selling part. The deal Headquartered in Pennsylvania, Shift4 provides more
Nicolas Wehrli has joined Loyens & Loeff ‘s Zurich office as a partner in the corporate and M&A practice group. Wehrli has extensive experience representing clients in complex M&A, private equity
Loyens & Loeff has appointed Christine Hohl (pictured) as local partner effective 1 May. Hohl advises clients in financing transactions including acquisition financings, asset financings, real estate financings, debt issuances and securitisations. Her clients include banks,
Investindustrial, a leading European group in the field of private equity, has signed an agreement through one of its investment vehicles for the entry of QuattroR into the capital of Medical Technology and Devices Group.
Robin Moser becomes Loyens & Loeff‘s fifth Swiss equity partner with effect from 1 January 2023. He joined Loyens & Loeff in 2019 and heads the Litigation and Risk Management department in the Zurich office. The law
Harmen Holtrop and Roderik Beckers were appointed to the Executive Board of Loyens & Loeff on 6 October 2022. They were appointed at the Annual General Meeting in Amsterdam (The Netherlands) and succeed Bram Linnartz and Thierry
Solvias, an independent pharmaceutical testing and manufacturing company, has acquired Netherlands-based Cergentis to bolster its biologics and cell & gene therapy testing capabilities. Cergentis marks Solvias’ second acquisition since partnering with health care investors Water
